192 related articles for article (PubMed ID: 8108798)
1. [The allergic deworming syndrome in opisthorchiasis].
Zhukov NA; Klimova SK
Ter Arkh; 1993; 65(11):49-53. PubMed ID: 8108798
[No Abstract] [Full Text] [Related]
2. [The effect of various factors on the immune status of patients with chronic opisthorchiasis. 2. Changes in immunologic indices in patients with chronic opisthorchiasis undergoing chloxyl treatment for various lengths of time].
Buzhak NS; Lepekhin AV; Ratner GM; Kondrat'eva ML
Med Parazitol (Mosk); 1989; (5):21-4. PubMed ID: 2615702
[TBL] [Abstract][Full Text] [Related]
3. [The cellular immunity link in children with chronic opisthorchiasis before and after chloxyl treatment].
Pomogaeva AP; Lavrova KV; Pozdeeva LP; Shurupova AV
Med Parazitol (Mosk); 1987; (5):31-4. PubMed ID: 3437837
[No Abstract] [Full Text] [Related]
4. [The effect of the anthelmintics biltricide and chloxyl on the level of cellular and humoral immunity in patients with chronic opisthorchiasis].
Lepekhin AV; Buzhak NS; Kondrat'eva ML; Ratner GM
Med Parazitol (Mosk); 1991; (2):11-3. PubMed ID: 2067484
[TBL] [Abstract][Full Text] [Related]
5. [The early deworming of pseudotuberculosis patients with chronic opisthorchiasis].
Chuĭkova KI
Med Parazitol (Mosk); 1993; (2):23-5. PubMed ID: 8028561
[No Abstract] [Full Text] [Related]
6. [Cellular and humoral immunity and nonspecific resistance factors in chronic opisthorchiasis patients during dispensary observation].
Lepekhin AV; Vasil'ev NV; Buzhak NS; Ratner GM; Portniagina LK
Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):50-4. PubMed ID: 3630481
[TBL] [Abstract][Full Text] [Related]
7. [Comparative effectiveness of praziquantel and chloxyl in experimental opisthorchiasis in golden hamsters].
Krotov AI; Cherniaeva AI; Baiandina DG; Gitsu GA
Med Parazitol (Mosk); 1982; 60(2):52-4. PubMed ID: 7093012
[No Abstract] [Full Text] [Related]
8. Praziquantel compared to hexachloroparaxylol in the treatment of far eastern liver fluke infestation of man.
Ziegler K; Moeller FW; Lafrenz M
Bull Inst Marit Trop Med Gdynia; 1982; 33(3-4):195-201. PubMed ID: 7188314
[No Abstract] [Full Text] [Related]
9. [Recurrent forms of opisthorchiasis].
Belov GF; Krasnova EI; Kuznetsova VG
Med Parazitol (Mosk); 1994; (2):19-21. PubMed ID: 7935182
[TBL] [Abstract][Full Text] [Related]
10. [The mass treatment of opisthorchiasis with praziquantel from the viewpoints of the clinician and the epidemiologist].
Ozeretskovskaia NN; Sergiev VP
Med Parazitol (Mosk); 1993; (5):6-13. PubMed ID: 8127275
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-immunologic indicators in children with opisthorchiasis in relation to the use of various anthelmintics].
Levakhina NM; Krivtsova LA
Pediatriia; 1990; (2):51-4. PubMed ID: 2190171
[No Abstract] [Full Text] [Related]
12. [Diagnosis and treatment of cholelithiasis in opisthorchiasis patients].
Kirilenko MP; Molov IS
Khirurgiia (Mosk); 1982 Jun; (6):80-3. PubMed ID: 7120808
[No Abstract] [Full Text] [Related]
13. [Clinico-immunologic indices of various patient contingents in a focus of chronic opisthorchiasis. 3. Dynamics of the indices following praziquantel treatment].
Parfenov SB; Ozeretskovskaia NN; Pomigalov AIu; Chistiakova IV
Med Parazitol (Mosk); 1989; (4):72-5. PubMed ID: 2811752
[TBL] [Abstract][Full Text] [Related]
14. [Intrahepatic circulatory function in chronic opisthorchiasis of children and changes in intrahepatic blood flow during chloxyl treatment].
Kashuba EA; Orlov MD; Krylov VI; Manannikov VP
Med Parazitol (Mosk); 1984; (5):16-20. PubMed ID: 6513868
[No Abstract] [Full Text] [Related]
15. [The procedure for the wide use of praziquantel in a complex of measures to control opisthorchiasis. 2. The tolerance and efficacy of Russian-made azinox in mass treatment in foci].
Zavoĭkin VD; Mikhaĭlov MM; Zelia OP; Bronshteĭn AM; Firsova RA; Sokerina OA; Gerasimov IV; Gorbunov NS; Kostyrev EP
Med Parazitol (Mosk); 1995; (3):32-4. PubMed ID: 7476679
[TBL] [Abstract][Full Text] [Related]
16. [Dynamics of antibody and antigen titers in opisthorchiasis patients following effective treatment].
Teplukhin IuV; Karal'nik BV; Gorbunova LA; Nikitiuk GV; Slemnev VF
Med Parazitol (Mosk); 1988; (5):34-7. PubMed ID: 2472547
[No Abstract] [Full Text] [Related]
17. [Vitamin C metabolism of opisthorchiasis patients in various phases of the infection and in the residual period].
Nalobin VA; Nalobin AV
Med Parazitol (Mosk); 1988; (4):58-60. PubMed ID: 3193923
[No Abstract] [Full Text] [Related]
18. A clinical trial of oral dehydroemetine in opisthorchiasis.
Muangmanee L; Aswapokee N; Jaroonvesama N; Viranuvatti V
Southeast Asian J Trop Med Public Health; 1974 Dec; 5(4):581-5. PubMed ID: 4617315
[No Abstract] [Full Text] [Related]
19. [Toxic-allergic syndrome in patients with chronic opisthorchiasis with skin manifestations].
Filimonova LA; Tsukanov VV; Prokhorenkov VI; Borisenko NA
Eksp Klin Gastroenterol; 2002; (1):98-9. PubMed ID: 12271598
[No Abstract] [Full Text] [Related]
20. [Evaluation of our experience with the wide use of chloxyl for treating opisthorchiasis].
Skarednov NI; Stepanova TF
Med Parazitol (Mosk); 1986; (5):14-8. PubMed ID: 3796447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
